Advertisement.

ALGS Projected Dividend Yield

Aligos Therapeutics Inc ( NASDAQ : ALGS )

Aligos Therapeutics is a clinical-stage biopharmaceutical company focused on developing therapeutics to address unmet medical needs in liver diseases and viral infections, including in the areas of non-alcoholic steatohepatitis (NASH), coronavirus (e.g., Severe Acute Respiratory Syndrome coronavirus 2 and related infections) and chronic hepatitis B. Co.'s primary area of focus is NASH, a chronic liver disease. Co.'s primary drug candidate for NASH is ALG-055009, a small molecule thyroid hormone receptor agonist. This drug candidate is being evaluated in a Phase 1 study in healthy volunteers (oral single ascending doses and subjects with hyperlipidemia (14 oral daily doses).

20 YEAR PERFORMANCE RESULTS

ALGS Dividend History Detail
ALGS Dividend News
ALGS Competitors News

# of Shares: 0

Closing Price: 34.07

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000